Heat shock protein-90 dampens and directs signaling stimulated by insulin-like growth factor-1 and insulin

被引:30
|
作者
Meares, GP [1 ]
Zmijewska, AA [1 ]
Jope, RS [1 ]
机构
[1] Univ Alabama, Dept Psychiat & Behav Neurobiol, Sparks Ctr 1057, Birmingham, AL 35294 USA
来源
FEBS LETTERS | 2004年 / 574卷 / 1-3期
关键词
heat shock protein-90; Akt; protein kinase B; insulin; insulin-like growth factor-1;
D O I
10.1016/j.febslet.2004.08.026
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Heat shock protein-90 (Hsp90) buffers cells from genetic mutations and environmental stresses. To test if this capability reflects a normal physiological function of Hsp90 to buffer cellular signals, the effects of Hsp90 inhibition were measured on activation of Akt. Inhibition of Hsp90 with geldanamycin amplified Akt phosphorylation induced by insulin-like growth factor-1 (IGF-1) or insulin, indicating that Hsp90 normally buffers these signals. Furthermore, with IGF-1 stimulation Hsp90 inhibition increased p38 activation, produced additive activation of p90RSK, and slightly increased the duration of ERK1/2 activation. Hsp90 dampened Akt signaling by facilitating phosphatase-mediated dephosphorylation of Akt. Thus, Hsp90 not only buffers the cellular effects of mutations and stresses, but also buffers the magnitude and duration of activation of proliferative and survival-promoting signaling responses. (C) 2004 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
引用
收藏
页码:181 / 186
页数:6
相关论文
共 50 条
  • [21] Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein-3: Genetic factors
    Morimoto, LM
    Newcomb, PA
    White, E
    Bigler, J
    Potter, JD
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (06) : 1394 - 1401
  • [22] Growth hormone, insulin, and insulin-like growth factor-1 in hypermobility syndrome
    Denko, CW
    Boja, B
    JOURNAL OF RHEUMATOLOGY, 2001, 28 (07) : 1666 - 1669
  • [23] Intracellular zinc fluctuations modulate protein tyrosine phosphatase activity in insulin/insulin-like growth factor-1 signaling
    Haase, H
    Maret, W
    EXPERIMENTAL CELL RESEARCH, 2003, 291 (02) : 289 - 298
  • [24] The role of insulin and insulin-like growth factor-1 in mammalian ageing
    Richardson, A
    Liu, F
    Adamo, ML
    Van Remmen, H
    Nelson, JF
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 18 (03) : 393 - 406
  • [25] Insulin, insulin-like growth factor-1, insulin receptor, and insulin-like growth factor-1 receptor expression in the chick eye and their regulation with imposed myopic or hyperopic defocus
    Penha, Alexandra Marcha
    Schaeffel, Frank
    Feldkaemper, Marita
    MOLECULAR VISION, 2011, 17 (162): : 1436 - 1448
  • [26] Polymorphisms In The Insulin Growth Factor Pathway, And Circulating Insulin-Like Growth Factor-1 And Insulin-Like Growth Factor Binding Protein-3 In Medical Critical Illness
    Ahasic, A. M.
    Tejera, P.
    Wei, Y.
    Su, L.
    Mantzoros, C.
    Thompson, B. T.
    Christiani, D. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [27] Dysregulation of insulin-like growth factor-1 signaling in postnatal bone elongation
    White, Cassaundra A.
    Serrat, Maria A.
    BIOCHEMISTRY AND CELL BIOLOGY, 2023, 101 (05) : 388 - 393
  • [28] The Role of Insulin-like Growth Factor-1 Signaling Pathways in Uterine Leiomyoma
    Gkioka, Eliona
    Msaouel, Pavlos
    Philippou, Anastassios
    Vlachogiannis, Nikolaos I.
    Vogkou, Christiana T.
    Margiolis, Argyris
    Koutsilieris, Michael
    IN VIVO, 2015, 29 (06): : 637 - 649
  • [29] Role of insulin-like growth factor-1 signaling in dental fibroblast apoptosis
    Han, XZ
    Amar, S
    JOURNAL OF PERIODONTOLOGY, 2003, 74 (08) : 1176 - 1182
  • [30] THE ROLE OF INSULIN-LIKE GROWTH FACTOR-1 ON STEATOHEPATITIS
    Bulur, O.
    Dal, K.
    Ertugrul, D. T.
    Aydogan, Y.
    Beyan, E.
    Karadag, I
    Unsal, O.
    VALUE IN HEALTH, 2016, 19 (07) : A839 - A839